Haematologica
(Aug 2022)
Investigational venetoclax combination therapy in acute myeloid leukemia – a systematic review and meta-analysis
- Shai Shimony,
- Alon Rozental,
- Jan P. Bewersdorf,
- Aaron D. Goldberg,
- Eytan M. Stein,
- Alyssa A. Grimshaw,
- Richard M. Stone,
- Daniel J. DeAngelo,
- Ofir Wolach,
- Maximilian Stahl
Affiliations
- Shai Shimony
- Medical Oncology, Dana Farber Cancer Institute, Boston, Ma, USA; Rabin Medical Center, Petah Tikva, Israel and Sackler Medical School, Aviv
- Alon Rozental
- Rabin Medical Center, Petah Tikva, Israel and Sackler Medical School, Aviv
- Jan P. Bewersdorf
- Leukemia Service, Memorial Sloan Kettering Cancer Center, New York City, NY
- Aaron D. Goldberg
- Leukemia Service, Memorial Sloan Kettering Cancer Center, New York City, NY
- Eytan M. Stein
- Leukemia Service, Memorial Sloan Kettering Cancer Center, New York City, NY
- Alyssa A. Grimshaw
- Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT
- Richard M. Stone
- Medical Oncology, Dana Farber Cancer Institute, Boston, Ma
- Daniel J. DeAngelo
- Medical Oncology, Dana Farber Cancer Institute, Boston, Ma
- Ofir Wolach
- Rabin Medical Center, Petah Tikva, Israel and Sackler Medical School, Aviv
- Maximilian Stahl
- Medical Oncology, Dana Farber Cancer Institute, Boston, Ma
- DOI
-
https://doi.org/10.3324/haematol.2022.281453
- Journal volume & issue
-
Vol. 107,
no. 12
WeChat QR code